Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2024-05-29 00:00:00 ET · period of report 2024-05-28 · accession 0000950170-24-066175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-05-29 | 2024-05-28+ | AXSM | Coleman Mark | Dir | S - Sale | $75.18 | -10.5K | 14.6K | -42% | -$789.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | S | D | 5,249 | $75.21 | 19,848 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.88. |
| 2 | Common | Common Stock | 2024-05-29 | S | D | 5,248 | $75.14 | 14,600 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.90. |